{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T17:02:35Z","timestamp":1732035755042},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00228-015-1951-7","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T23:48:36Z","timestamp":1443224916000},"page":"1509-1516","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Simplification of a pharmacokinetic model for red blood cell methotrexate disposition"],"prefix":"10.1007","volume":"71","author":[{"given":"Shan","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Korell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Duffull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/art.20167","volume":"50","author":"CM Lambert","year":"2004","unstructured":"Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V (2004) Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Arthritis Rheum 50:364\u2013371","journal-title":"Arthritis Rheum"},{"key":"1951_CR2","doi-asserted-by":"crossref","first-page":"978396","DOI":"10.1155\/2012\/978396","volume":"2012","author":"KI Halilova","year":"2012","unstructured":"Halilova KI, Brown EE, Morgan SL, Bridges SL Jr, Hwang MH, Arnett DK, Danila MI (2012) Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol 2012:978396\u2013978402","journal-title":"Int J Rheumatol"},{"key":"1951_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40262-013-0052-y","volume":"52","author":"J Korell","year":"2013","unstructured":"Korell J, Stamp LK, Barclay ML, Dalrymple JM, Drake J, Zhang M, Duffull SB (2013) A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cells. Clin Pharmacokinet 52:475\u2013485","journal-title":"Clin Pharmacokinet"},{"key":"1951_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/cr950223l","volume":"98","author":"MS Okino","year":"1998","unstructured":"Okino MS, Mavrovouniotis ML (1998) Simplification of mathematical models of chemical reaction systems. Chem Rev 98:391\u2013408","journal-title":"Chem Rev"},{"key":"1951_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0083-6729(03)01012-4","volume":"66","author":"LH Matherly","year":"2003","unstructured":"Matherly LH, Goldman DI (2003) Membrane transport of folates. Vitam Horm 66:403\u2013456","journal-title":"Vitam Horm"},{"key":"1951_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/FTD.0b013e31811f39bb","volume":"29","author":"AJ Brooks","year":"2007","unstructured":"Brooks AJ, Begg EJ, Zhang M, Frampton CM, Barclay ML (2007) Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease. Ther Drug Monit 29:619\u2013625","journal-title":"Ther Drug Monit"},{"key":"1951_CR7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40262-014-0179-5","volume":"53","author":"S Pan","year":"2014","unstructured":"Pan S, Stamp L, Duffull S, Barclay M, Dalrymple J, Drake J, Zhang M, Korell J (2014) Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. Clin Pharmacokinet 53:1161\u20131170","journal-title":"Clin Pharmacokinet"},{"key":"1951_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pst.1509","volume":"11","author":"LK Foo","year":"2012","unstructured":"Foo LK, McGree J, Duffull S (2012) A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies. Pharm Stat 11:325\u2013333","journal-title":"Pharm Stat"},{"key":"1951_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/i160029a019","volume":"8","author":"J Wei","year":"1969","unstructured":"Wei J, Kuo JCW (1969) Lumping analysis in monomolecular reaction systems. Analysis of the exactly lumpable system. Ind Eng Chem Fundam 8:114\u2013123","journal-title":"Ind Eng Chem Fundam"},{"key":"1951_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1049\/iet-syb:20070055","volume":"3","author":"A Dokoumetzidis","year":"2009","unstructured":"Dokoumetzidis A, Aarons L (2009) Proper lumping in systems biology models. IET Syst Biol 3:40\u201351","journal-title":"IET Syst Biol"},{"key":"1951_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.67","volume":"3","author":"A Gulati","year":"2014","unstructured":"Gulati A, Isbister GK, Duffull SB (2014) Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data. CPT Pharmacometrics Syst Pharmacol 3, e90","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1951_CR12","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/art.24034","volume":"58","author":"JM Dalrymple","year":"2008","unstructured":"Dalrymple JM, Stamp LK, O'Donnell JL, Chapman PT, Zhang M, Barclay ML (2008) Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 58:3299\u20133308","journal-title":"Arthritis Rheum"},{"key":"1951_CR13","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3899\/jrheum.110481","volume":"38","author":"LK Stamp","year":"2011","unstructured":"Stamp LK, Barclay ML, O'Donnell JL, Zhang M, Drake J, Frampton C, Chapman PT (2011) Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. J Rheumatol 38:2540\u20132547","journal-title":"J Rheumatol"},{"key":"1951_CR14","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.25","volume":"2","author":"V Shivva","year":"2013","unstructured":"Shivva V, Korell J, Tucker IG, Duffull SB (2013) An approach for identifiability of population pharmacokinetic-pharmacodynamic models. CPT Pharmacometrics Syst Pharmacol 2, e49","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"1951_CR15","unstructured":"Duffull SB, Denman N, Kimko H, Eccleston J (2012) Population OPTimal design. In POPT\u2014installation and user guide. Available from: http:\/\/www.winpopt.com\/"},{"key":"1951_CR16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00228-014-1740-8","volume":"70","author":"H Al-Sallami","year":"2014","unstructured":"Al-Sallami H, Cheah S, Han S, Liew J, Lim J, Ng M, Solanki H, Soo R, Tan V, Duffull S (2014) Between-subject variability: should high be the new normal? Eur J Clin Pharmacol 70:1403\u20131404","journal-title":"Eur J Clin Pharmacol"},{"key":"1951_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bcp.12352","volume":"79","author":"J Nyberg","year":"2015","unstructured":"Nyberg J, Bazzoli C, Ogungbenro K, Aliev A, Leonov S, Duffull S, Hooker AC, Mentre F (2015) Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies. Br J Clin Pharmacol 79:6\u201317","journal-title":"Br J Clin Pharmacol"},{"key":"1951_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cmpb.2007.07.002","volume":"88","author":"G Bellu","year":"2007","unstructured":"Bellu G, Saccomani MP, Audoly S, D'Angio L (2007) DAISY: a new software tool to test global identifiability of biological and physiological systems. Comput Methods Prog Biomed 88:52\u201361","journal-title":"Comput Methods Prog Biomed"},{"key":"1951_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF01070904","volume":"9","author":"D D'Argenio","year":"1981","unstructured":"D'Argenio D (1981) Optimal sampling times for pharmacokinetic experiments. J Pharmacokinet Biopharm 9:739\u2013756","journal-title":"J Pharmacokinet Biopharm"},{"key":"1951_CR20","doi-asserted-by":"crossref","unstructured":"Foo LK, Duffull SB (2011) Optimal design of pharmacokinetic\u2013pharmacodynamic studies. In: Bonate PL, Howard DR (eds) Pharmacokinetics in drug development. Springer US, pp 175\u2013193","DOI":"10.1007\/978-1-4419-7937-7_8"},{"key":"1951_CR21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10928-014-9391-z","volume":"41","author":"C Steven Ernest 2nd","year":"2014","unstructured":"Steven Ernest C 2nd, Nyberg J, Karlsson MO, Hooker AC (2014) Optimal clinical trial design based on a dichotomous Markov-chain mixed-effect sleep model. J Pharmacokinet Pharmacodyn 41:639\u2013654","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1951-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1951-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:49:14Z","timestamp":1558702154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1951-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1951-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]}}}